[Steroid-Dependent Nephrotic Syndrome Due to Minimal Change Glomerulonephritis Treated with Rituximab].
G Ital Nefrol
; 41(1)2024 Feb 28.
Article
en It
| MEDLINE
| ID: mdl-38426681
ABSTRACT
47-year-old woman suffering from minimal lesion glomerulonephritis previously undergone high-dose steroid therapy and subjected to exacerbations of nephrotic syndrome after therapy discontinuation. It was decided to initiate off-label treatment with Rituximab at a dosage of 375 mg/m2 administred at zero-time, one-month and three months with good therapeutic response and resolution of the clinical laboratory picture. The therapy was well tolerated and had no side effects. This scheme could be an alternative to the conventional therapeutic scheme with steroids or other classes of immunosuppressive drugs, especially in order to avoid problems related to prolonged exposure to steroid therapy.
Palabras clave
Buscar en Google
Base de datos:
MEDLINE
Asunto principal:
Nefrosis Lipoidea
/
Síndrome Nefrótico
Límite:
Female
/
Humans
Idioma:
It
Revista:
G Ital Nefrol
Asunto de la revista:
NEFROLOGIA
Año:
2024
Tipo del documento:
Article